These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
966 related items for PubMed ID: 25840978
21. Assessment of blood pool, soft tissue, and skeletal uptake of sodium fluoride F 18 with positron emission tomography-computed tomography in four clinically normal dogs. Valdés-Martínez A, Kraft SL, Brundage CM, Arceneaux BK, Stewart JA, Gibbons DS. Am J Vet Res; 2012 Oct; 73(10):1589-95. PubMed ID: 23013185 [Abstract] [Full Text] [Related]
23. Is there any complimentary role of F-18 NaF PET/CT in detecting of osseous involvement of multiple myeloma? A comparative study for F-18 FDG PET/CT and F-18 FDG NaF PET/CT. Ak İ, Onner H, Akay OM. Ann Hematol; 2015 Sep; 94(9):1567-75. PubMed ID: 26068066 [Abstract] [Full Text] [Related]
24. The Role of 18F-FDG PET/CT in the evaluation of Ascites of Undetermined Origin. Zhang M, Jiang X, Zhang M, Xu H, Zhai G, Li B. J Nucl Med; 2009 Apr; 50(4):506-12. PubMed ID: 19289438 [Abstract] [Full Text] [Related]
27. [Value of 18F-FDG and 11C-MET PET-CT in differentiation of brain ringlike-enhanced neoplastic and non-neoplastic lesions on MRI imaging]. Cai L, Gao S, Li DC, Li YS, Chen QS, Xing XL. Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):134-8. PubMed ID: 19538892 [Abstract] [Full Text] [Related]
28. Incremental Value of Cocktail 18F-FDG and 18F-NaF PET/CT Over 18F-FDG PET/CT Alone for Characterization of Skeletal Metastases in Breast Cancer. Roop MJ, Singh B, Singh H, Watts A, Kohli PS, Mittal BR, Singh G. Clin Nucl Med; 2017 May; 42(5):335-340. PubMed ID: 28263210 [Abstract] [Full Text] [Related]
29. Prospective evaluation of 18F-NaF and 18F-FDG PET/CT in detection of occult metastatic disease in biochemical recurrence of prostate cancer. Jadvar H, Desai B, Ji L, Conti PS, Dorff TB, Groshen SG, Gross ME, Pinski JK, Quinn DI. Clin Nucl Med; 2012 Jul; 37(7):637-43. PubMed ID: 22691503 [Abstract] [Full Text] [Related]
31. Utility of 18F-FDG PET/CT in the diagnosis and staging of extramammary Paget's disease. Tian Y, Wu HB, Li DL, Li HS, Zhou WL, Wang QS. Nucl Med Commun; 2015 Sep; 36(9):892-7. PubMed ID: 25932540 [Abstract] [Full Text] [Related]
33. Evaluation of the Outcome of Lung Nodules Missed on 18F-FDG PET/MRI Compared with 18F-FDG PET/CT in Patients with Known Malignancies. Sawicki LM, Grueneisen J, Buchbender C, Schaarschmidt BM, Gomez B, Ruhlmann V, Umutlu L, Antoch G, Heusch P. J Nucl Med; 2016 Jan; 57(1):15-20. PubMed ID: 26514173 [Abstract] [Full Text] [Related]
34. Standardized uptake value differences between primary and metastatic lesions in ¹⁸F-FDG PET/CT of patients with lung cancer. Kosaka N, Tsuchida T, Tsuji K, Shimizu K, Kimura H. Acta Radiol; 2015 Nov; 56(11):1329-35. PubMed ID: 25398775 [Abstract] [Full Text] [Related]
35. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate. Sachpekidis C, Mai EK, Goldschmidt H, Hillengass J, Hose D, Pan L, Haberkorn U, Dimitrakopoulou-Strauss A. Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508 [Abstract] [Full Text] [Related]